1. The Double-Edged Sword Profile of Redox Signaling: Oxidative Events as Molecular Switches in the Balance Between Cell Physiology and Cancer
    Sonia Emanuele et al, 2018, Chem. Res. Toxicol. CrossRef
  2. Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases
    Bee Ling Tan et al, 2018, Front. Pharmacol. CrossRef
  3. Sophora Tomentosa Extract Prevents MPTP-Induced Parkinsonism in C57BL/6 Mice Via the Inhibition of GSK-3β Phosphorylation and Oxidative Stress
    Hung-Chi Chang et al, 2019, Nutrients CrossRef
  4. Noxious Iron–Calcium Connections in Neurodegeneration
    Marco Tulio Núñez et al, 2019, Front. Neurosci. CrossRef
  5. EDTA Chelation Therapy for the Treatment of Neurotoxicity
    Fulgenzi Alessandro et al, 2019, IJMS CrossRef
  6. null
    M. Diana Neely et al, 2019 CrossRef
  7. Vascular Dysfunction Induced by Mercury Exposure
    Tetsuya Takahashi et al, 2019, IJMS CrossRef
  8. The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson’s Disease (PD) and Major Depressive Disorder (MDD)
    Kai Yang et al, 2019, Front. Pharmacol. CrossRef
  9. PERK-Mediated Unfolded Protein Response Activation and Oxidative Stress in PARK20 Fibroblasts
    Giuseppina Amodio et al, 2019, Front. Neurosci. CrossRef
  10. Neuroprotective Effects of Methanolic Extract of Avocado Persea americana (var. Colinred) Peel on Paraquat-Induced Locomotor Impairment, Lipid Peroxidation and Shortage of Life Span in Transgenic knockdown Parkin Drosophila melanogaster
    Hector Flavio Ortega-Arellano et al, 2019, Neurochem Res CrossRef
  11. On the Neurobiological Role of Oxidative Stress in Alcohol-Induced Impulsive, Aggressive and Suicidal Behavior
    Tobore Onojighofia Tobore, 2019, Substance Use & Misuse CrossRef
  12. Dopamine in the Pathophysiology of Preeclampsia and Gestational Hypertension: Monoamine Oxidase (MAO) and Catechol-O-methyl Transferase (COMT) as Possible Mechanisms
    Wendy N. Phoswa, 2019, Oxidative Medicine and Cellular Longevity CrossRef
  13. Neuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain
    Małgorzata Kujawska et al, 2019, IJMS CrossRef
  14. 6-Hydroxydopamine: a far from simple neurotoxin
    Damir Varešlija et al, 2020, J Neural Transm CrossRef
  15. Inhibition of Mitochondrial ROS by MitoQ Alleviates White Matter Injury and Improves Outcomes after Intracerebral Haemorrhage in Mice
    Weixiang Chen et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  16. Emerging Role of Sirtuin 2 in Parkinson’s Disease
    Yumei Liu et al, 2020, Front. Aging Neurosci. CrossRef
  17. Effect of Curcumin on Protein Damage Induced by Rotenone in Dopaminergic PC12 Cells
    Sandra Buratta et al, 2020, IJMS CrossRef
  18. Neuroprotective Effect of Bergamot Juice in 6-OHDA-Induced SH-SY5Y Cell Death, an In Vitro Model of Parkinson’s Disease
    Nadia Ferlazzo et al, 2020, Pharmaceutics CrossRef
  19. Evidence of a Role for the TRPC Subfamily in Mediating Oxidative Stress in Parkinson’s Disease
    Daniele Maria-Ferreira et al, 2020, Front. Physiol. CrossRef
  20. Neuroprotection Against Parkinson’s Disease Through the Activation of Akt/GSK3β Signaling Pathway by Tovophyllin A
    Yanjun Huang et al, 2020, Front. Neurosci. CrossRef
  21. Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?
    Cristina Salado-Manzano et al, 2020, Front. Cell. Neurosci. CrossRef
  22. HSPB5 (αB-crystallin) confers protection against paraquat-induced oxidative stress at the organismal level in a tissue-dependent manner
    Prashanth Budnar et al, 2020, Cell Stress and Chaperones CrossRef
  23. Autophagy and Redox Homeostasis in Parkinson’s: A Crucial Balancing Act
    Natalia Jimenez-Moreno et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  24. Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration
    Morteza Sarparast et al, 2020, Nutrients CrossRef
  25. Intranigral Administration of β-Sitosterol-β-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra
    Claudia Luna-Herrera et al, 2020, Journal of Immunology Research CrossRef
  26. Idebenone Ameliorates Rotenone-Induced Parkinson’s Disease in Rats Through Decreasing Lipid Peroxidation
    Bahattin Avcı et al, 2020, Neurochem Res CrossRef
  27. Dietary Antioxidants and the Mitochondrial Quality Control: Their Potential Roles in Parkinson’s Disease Treatment
    Davin Lee et al, 2020, Antioxidants CrossRef
  28. Clinical and biochemical heterogeneity of Parkinson’s disease
    Kh.I. Khadzieva et al, 2020, Z. nevrol. psikhiatr. im. S.S. Korsakova CrossRef
  29. pH-Responsive Redox Nanoparticles Protect SH-SY5Y Cells at Lowered pH in a Cellular Model of Parkinson’s Disease
    Monika Pichla et al, 2021, Molecules CrossRef
  30. Amauroderma rugosum Protects PC12 Cells against 6-OHDA-Induced Neurotoxicity through Antioxidant and Antiapoptotic Effects
    Jingjing Li et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  31. Arbutin effectively ameliorates the symptoms of Parkinson’s disease: the role of adenosine receptors and cyclic adenosine monophosphate
    Jie Zhao et al, 2021, Neural Regen Res CrossRef
  32. Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures
    James P. Bennett et al, 2021, Biomedicines CrossRef
  33. Fermented Soy Products: Beneficial Potential in Neurodegenerative Diseases
    Chan Ho Jang et al, 2021, Foods CrossRef
  34. Emulated Clinical Trials from Longitudinal Real-World Data Efficiently Identify Candidates for Neurological Disease Modification: Examples from Parkinson’s Disease
    Daphna Laifenfeld et al, 2021, Front. Pharmacol. CrossRef
  35. The preventive effect of strawberries against the onset of common human diseases induced by oxidative stress
    D. Cianciosi et al, 2021, Acta Hortic. CrossRef
  36. MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review
    Yong Hui Nies et al, 2021, Front. Neurosci. CrossRef
  37. The Association between Anemia and Parkinson’s Disease: A Nested Case-Control Study Using a National Health Screening Cohort
    Ji Hee Kim et al, 2021, Brain Sciences CrossRef
  38. Neuroprotective effect of sesamol against aluminum nanoparticle-induced toxicity in rats
    Shimaa M. Abou-Zeid et al, 2021, Environ Sci Pollut Res CrossRef
  39. NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology
    Annelise Vermot et al, 2021, Antioxidants CrossRef
  40. Antioxidative Effects of Carrot-Derived Nanovesicles in Cardiomyoblast and Neuroblastoma Cells
    Do Kyung Kim et al, 2021, Pharmaceutics CrossRef
  41. Impact of Glucocorticoid on a Cellular Model of Parkinson’s Disease: Oxidative Stress and Mitochondrial Function
    Silvia Claros et al, 2021, Brain Sciences CrossRef
  42. Benefits of betanin in rotenone-induced Parkinson mice
    Wachiryah Thong-asa et al, 2021, Metab Brain Dis CrossRef
  43. Enzyme Therapy: Current Challenges and Future Perspectives
    Miguel de la Fuente et al, 2021, IJMS CrossRef
  44. A Novel Synthetic Precursor of Styryl Sulfone Neuroprotective Agents Inhibits Neuroinflammatory Responses and Oxidative Stress Damage through the P38 Signaling Pathway in the Cell and Animal Model of Parkinson’s Disease
    Ying Guo et al, 2021, Molecules CrossRef
  45. Functioning of the Antioxidant Defense System in Rotenone-Induced Parkinson’s Disease
    E. D. Kryl’skii et al, 2021, Bull Exp Biol Med CrossRef
  46. Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling
    Daniela Giovannini et al, 2021, Cell Death Discov. CrossRef
  47. A Narrative Review of Lifestyle Factors Associated with Parkinson’s Disease Risk and Progression
    Nupur Nag et al, 2019, Neurodegener Dis CrossRef
  48. Clinical and Biochemical Heterogeneity of Parkinson’s Disease
    Kh. I. Khadzieva et al, 2021, Neurosci Behav Physi CrossRef
  49. Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders
    Tahereh Ebrahimi et al, 2021, CSCR CrossRef
  50. Insulin-like Growth Factor II Prevents MPP+ and Glucocorticoid Mitochondrial-Oxidative and Neuronal Damage in Dopaminergic Neurons
    Silvia Claros et al, 2021, Antioxidants CrossRef
  51. One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration
    Eirini Lionaki et al, 2022, Cells CrossRef
  52. Mechanistic Insights Expatiating the Redox-Active-Metal-Mediated Neuronal Degeneration in Parkinson’s Disease
    Tapan Behl et al, 2022, IJMS CrossRef
  53. Cytokines, miRNAs, and Antioxidants as Combined Non-invasive Biomarkers for Parkinson’s Disease
    Amr Ghit et al, 2022, J Mol Neurosci CrossRef
  54. Reactive Oxygen Species: Angels and Demons in the Life of a Neuron
    Kasturi Biswas et al, 2022, NeuroSci CrossRef
  55. A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
    Vignayanandam Ravindernath-Jayashree Muddapu et al, 2022, Front. Neurosci. CrossRef
  56. Study on the Neuroprotective, Radical-Scavenging and MAO-B Inhibiting Properties of New Benzimidazole Arylhydrazones as Potential Multi-Target Drugs for the Treatment of Parkinson’s Disease
    Neda Anastassova et al, 2022, Antioxidants CrossRef
  57. Neuroprotective Effects of Cranberry Juice Treatment in a Rat Model of Parkinson’s Disease
    Łukasz Witucki et al, 2022, Nutrients CrossRef
  58. Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
    Yolanda Paes-Colli et al, 2022, Front. Cell. Neurosci. CrossRef
  59. Evaluation of betulinic acid effects on pain, memory, anxiety, catalepsy, and oxidative stress in animal model of Parkinson’s disease
    M. Abrishamdar et al, 2022, Metab Brain Dis CrossRef
  60. Antioxidant responses of Hericium erinaceus ingredients based on response surface methodology
    Huaqi He et al, 2021, IFRJ CrossRef
  61. The effects of transplanted adipose-derived multipotent mesenchymal stromal cells from mice of different age or from aging donors in combination with melatonin at experimental parkinsonism
    I. Labunets et al, 2022, COT CrossRef
  62. The Wnt/β-catenin signaling: a multifunctional target for neuroprotective and regenerative strategies in Parkinson’s disease
    Annalucia Serafino et al, 2023, Neural Regen Res CrossRef
  63. The Hidden Notes of Redox Balance in Neurodegenerative Diseases
    Silvia Piccirillo et al, 2022, Antioxidants CrossRef
  64. A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease
    Ozlem Bahadır Acıkara et al, 2022, CNSNDDT CrossRef
  65. Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson’s disease
    Hantao Zhang et al, 2022, Front. Aging Neurosci. CrossRef
  66. 1α,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson’s Disease
    Erlânia Alves de Siqueira et al, 2022, Neurochem Res CrossRef
  67. Assessment of Correlation Analysis, Phytochemical Profile, and Biological Activities of Endemic Scorzonera Species from Turkey
    Sezen Yılmaz Sarıaltın et al, 2022, Chemistry & Biodiversity CrossRef
  68. Effects of Brain Factor‑7® against motor deficit and oxidative stress in a mouse model of MPTP‑induced Parkinson's disease
    Tae-Kyeong Lee et al, 2022, Exp Ther Med CrossRef
  69. Trimethylamine N-oxide: role in cell senescence and age-related diseases
    Lin Zhang et al, 2022, Eur J Nutr CrossRef
  70. The two faces of DNA oxidation in genomic and functional mosaicism during aging in human neurons
    Michael A. Lodato et al, 2022, Front. Aging CrossRef
  71. Is Caperatic Acid the Only Compound Responsible for Activity of Lichen Platismatia glauca within the Nervous System?
    Elżbieta Studzińska-Sroka et al, 2022, Antioxidants CrossRef
  72. Europinidin Inhibits Rotenone-Activated Parkinson’s Disease in Rodents by Decreasing Lipid Peroxidation and Inflammatory Cytokines Pathways
    Ali Altharawi et al, 2022, Molecules CrossRef
  73. Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
    Luca Soraci et al, 2022, J Neurol CrossRef
  74. Implications of p53 in mitochondrial dysfunction and Parkinson’s disease
    YI-FANG WANG et al, 2022, International Journal of Neuroscience CrossRef
  75. Molecular Hydrogen: an Emerging Therapeutic Medical Gas for Brain Disorders
    Chongyun Wu et al, 2022, Mol Neurobiol CrossRef
  76. Traversing through the cell signaling pathways of neuroprotection by betanin: therapeutic relevance to Alzheimer’s Disease and Parkinson’s Disease
    Banashree Chetia Phukan et al, 2023, Metab Brain Dis CrossRef
  77. Neuroprotective Effect of farnesol against Rotenone Induced Parkinson’s Disease in Drosophila melanogaster
    Jayaram SARAVANAN et al, 2022, HUJPHARM CrossRef
  78. null
    Mahesh Pattabhiramaiah et al, 2022 CrossRef
  79. Protective Effect of Hirsutidin against Rotenone-Induced Parkinsonism via Inhibition of Caspase-3/Interleukins-6 and 1β
    Muhammad Shahid Nadeem et al, 2023, ACS Omega CrossRef
  80. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
    Dicson S. Malar et al, 2023, CNS Drugs CrossRef
  81. Impacts of methotrexate on survival, dendrite development, and synapse formation of cortical neurons
    Mai Yamamura et al, 2023, Genes to Cells CrossRef
  82. Therapeutic Approaches to Non-Motor Symptoms of Parkinson's Disease: A Current Update on Preclinical Evidence
    Poornima D.E. Weerasinghe-Mudiyanselage et al, 2023, CN CrossRef
  83. Вікові особливості ефектів мультипотентних мезенхімальних стромальних клітин жирової тканини мишей при експериментальному паркінсонізмі та зміни впливу клітин від старіючих донорів при використанні екзогенного мелатоніну
    I.F. Labunets et al, 2022, INJ CrossRef
  84. The Role of Nrf2 in Relieving Cerebral Ischemia-Reperfusion Injury
    Yu Sun et al, 2023, CN CrossRef
  85. Mitochondrial transport in symmetric and asymmetric axons with multiple branching junctions: a computational study
    Ivan A. Kuznetsov et al, 2023, Computer Methods in Biomechanics and Biomedical Engineering CrossRef
  86. Electrochemical micro- and nanobiosensors for in vivo reactive oxygen/nitrogen species measurement in the brain
    Fatemeh Beigloo et al, 2023 CrossRef
  87. The effects of human umbilical cord-derived multipotent mesenchymal stromal cells transplantation in mice of different strains with an experimental model of parkinsonism
    Iryna Labunets et al, 2023, COT CrossRef
  88. Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2
    Renata Perlikowska et al, 2023, Neurochem Res CrossRef
  89. Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases
    Yi Luan et al, 2024, J. Zhejiang Univ. Sci. B CrossRef
  90. Metallic Nanocarriers for Therapeutic Peptides: Emerging Solutions Addressing the Delivery Challenges in Brain Ailments
    Shanmuga Sharan Rathnam et al, 2024, J Pharmacol Exp Ther CrossRef
  91. The Interplay of Mitochondrial Bioenergetics and Dopamine Agonists as an Effective Disease-Modifying Therapy for Parkinson’s Disease
    null Neha et al, 2024, Mol Neurobiol CrossRef
  92. Identification of Hub Genes and Pathways of Middle Cerebral Artery Occlusion in Aged Rats Using the Gene Expression Omnibus Database
    Jing Guo et al, 2024, Crit Rev Immunol CrossRef
  93. Advancements in Single-Cell RNA Sequencing Research for Neurological Diseases
    Bingjie Yang et al, 2024, Mol Neurobiol CrossRef
  94. A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress
    Sheng Li et al, 2024, Mol Cell Biochem CrossRef
  95. Microarray-based Analysis of Differential Gene Expression Profile in Rotenone-induced Parkinson’s Disease Zebrafish Model
    Yong Hui Nies et al, 2024, CNSNDDT CrossRef
  96. THE ROLE OF INDIVIDUAL NEUROINFLAMMATION MOLECULES IN PATHOGENESIS ISCHEMIC STROKE. PART I
    А. Yu. Ma-Van-de et al, 2024, jour CrossRef
  97. SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum
    Valentina Naef et al, 2024, Ann Clin Transl Neurol CrossRef